In addition, the infiltration amounts of tumor-infiltrating immune cells in gliomas with isocitrate dehydrogenase (IDH) mutation and chromosome 1p/19q codeletion are lower than those with wild-type IDH or 1p/19q non-codeletion (25–27). The gene discussed is IDH1; the disease is central nervous system cancer.